Kurs & Likviditet
Kalender
| 2025-02-20 | Bokslutskommuniké 2024 |
| 2024-10-24 | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | Extra Bolagsstämma 2024 |
| 2024-07-18 | Kvartalsrapport 2024-Q2 |
| 2024-05-06 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2024-05-06 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2024-05-03 | Årsstämma 2024 |
| 2024-04-18 | Kvartalsrapport 2024-Q1 |
| 2024-02-22 | Bokslutskommuniké 2023 |
| 2023-10-26 | Kvartalsrapport 2023-Q3 |
| 2023-07-20 | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2023-05-08 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2023-05-05 | Årsstämma 2023 |
| 2023-04-20 | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | Bokslutskommuniké 2022 |
| 2022-10-27 | Kvartalsrapport 2022-Q3 |
| 2022-07-22 | Kvartalsrapport 2022-Q2 |
| 2022-05-09 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2022-05-09 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2022-05-06 | Årsstämma 2022 |
| 2022-04-22 | Kvartalsrapport 2022-Q1 |
| 2022-02-24 | Bokslutskommuniké 2021 |
| 2021-10-27 | Kvartalsrapport 2021-Q3 |
| 2021-07-23 | Kvartalsrapport 2021-Q2 |
| 2021-04-26 | X-dag ordinarie utdelning ADDV B 0.02 SEK |
| 2021-04-26 | X-dag ordinarie utdelning ADDV A 0.02 SEK |
| 2021-04-23 | Årsstämma 2021 |
| 2021-04-23 | Kvartalsrapport 2021-Q1 |
| 2021-02-25 | Bokslutskommuniké 2020 |
| 2020-10-23 | Kvartalsrapport 2020-Q3 |
| 2020-07-24 | Kvartalsrapport 2020-Q2 |
| 2020-04-27 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2020-04-27 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2020-04-24 | Årsstämma 2020 |
| 2020-04-24 | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | Bokslutskommuniké 2019 |
| 2019-10-22 | Kvartalsrapport 2019-Q3 |
| 2019-07-23 | Kvartalsrapport 2019-Q2 |
| 2019-04-26 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2019-04-26 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2019-04-25 | Kvartalsrapport 2019-Q1 |
| 2019-04-25 | Årsstämma 2019 |
| 2019-03-12 | Extra Bolagsstämma 2019 |
| 2019-02-21 | Bokslutskommuniké 2018 |
| 2018-10-25 | Kvartalsrapport 2018-Q3 |
| 2018-07-26 | Kvartalsrapport 2018-Q2 |
| 2018-05-04 | Kvartalsrapport 2018-Q1 |
| 2018-04-27 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2018-04-27 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2018-04-26 | Årsstämma 2018 |
| 2018-02-16 | Bokslutskommuniké 2017 |
| 2017-10-31 | Kvartalsrapport 2017-Q3 |
| 2017-07-26 | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | Kvartalsrapport 2017-Q1 |
| 2017-04-28 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2017-04-28 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2017-04-27 | Årsstämma 2017 |
| 2017-02-23 | Bokslutskommuniké 2016 |
| 2016-11-14 | Kvartalsrapport 2016-Q3 |
| 2016-08-18 | Kvartalsrapport 2016-Q2 |
| 2016-05-23 | Kvartalsrapport 2016-Q1 |
| 2016-04-27 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2016-04-27 | X-dag ordinarie utdelning ADDV B 0.00 SEK |
| 2016-04-26 | Årsstämma 2016 |
| 2016-02-22 | Bokslutskommuniké 2015 |
| 2015-11-10 | Kvartalsrapport 2015-Q3 |
| 2015-08-17 | Kvartalsrapport 2015-Q2 |
| 2015-05-22 | Kvartalsrapport 2015-Q1 |
| 2015-04-27 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2015-04-24 | Årsstämma 2015 |
| 2015-02-19 | Bokslutskommuniké 2014 |
| 2014-11-05 | Kvartalsrapport 2014-Q3 |
| 2014-08-15 | Kvartalsrapport 2014-Q2 |
| 2014-05-21 | Kvartalsrapport 2014-Q1 |
| 2014-04-10 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2014-04-09 | Årsstämma 2014 |
| 2014-02-20 | Bokslutskommuniké 2013 |
| 2013-11-05 | Kvartalsrapport 2013-Q3 |
| 2013-08-08 | Kvartalsrapport 2013-Q2 |
| 2013-05-20 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2013-05-17 | Årsstämma 2013 |
| 2013-05-14 | Kvartalsrapport 2013-Q1 |
| 2013-02-21 | Bokslutskommuniké 2012 |
| 2012-11-06 | Kvartalsrapport 2012-Q3 |
| 2012-08-09 | Kvartalsrapport 2012-Q2 |
| 2012-05-14 | Kvartalsrapport 2012-Q1 |
| 2012-04-02 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2012-03-30 | Årsstämma 2012 |
| 2012-02-23 | Bokslutskommuniké 2011 |
| 2011-11-04 | Kvartalsrapport 2011-Q3 |
| 2011-08-10 | Kvartalsrapport 2011-Q2 |
| 2011-05-05 | Kvartalsrapport 2011-Q1 |
| 2011-04-06 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2011-04-04 | Årsstämma 2011 |
| 2011-02-07 | Bokslutskommuniké 2010 |
| 2010-11-04 | Kvartalsrapport 2010-Q3 |
| 2010-08-12 | Kvartalsrapport 2010-Q2 |
| 2010-05-21 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2010-05-20 | Årsstämma 2010 |
| 2010-05-06 | Kvartalsrapport 2010-Q1 |
| 2009-09-25 | X-dag ordinarie utdelning ADDV A 0.00 SEK |
| 2009-09-24 | Årsstämma 1 |
| 2009-09-17 | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
ADDvise Group AB (publ) ("ADDvise Group") has initiated the process of listing the company's A and B shares on Nasdaq Stockholm. The change of listing venue is expected to be completed in the first quarter of 2025.
As part of the continued development of ADDvise Group, the company has for some time reviewed the possibility of changing its listing venue from Nasdaq First North to Nasdaq Stockholm main market. The Board of Directors believes that a change of listing venue would be beneficial for the company's continued development, provide a broader capital allocation toolkit, and increase the company's attractiveness to institutional investors. The Board of Directors and management have therefore initiated the process to change listing venue.
"We believe that ADDvise Group is ready to be listed on Nasdaq Stockholm main market. An uplisting is a stamp of quality and a natural next step in the company's development. Among other things, the change of listing venue would open up the possibility to buy back own shares, which is an important instrument in optimising our capital allocation" says Rikard Akhtarzand, CEO of ADDvise Group.
ADDvise Group's A and B shares have been listed on Nasdaq First North since 1998 and 2015 respectively. The change of listing venue to Nasdaq Stockholm is intended to take place without an offering or other sale of ADDvise Group's shares.
Further information will be provided closer to the time of uplisting.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 (0) 76-525 90 71
rikard.akhtarzand@addvisegroup.se
Oliver Humlen, CFO
+46 (0) 70-916 26 97
oliver.humlen@addvisegroup.se
Important information
This information is such that ADDvise Group AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons above, on May 7, 2024, at 08:30 CEST.
About ADDvise
ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 2 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se,is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.